Results 181 to 190 of about 39,072 (265)

Antinociceptive effect of Arvelexin in male mouse models. [PDF]

Sci Rep
Bseiso Y, Gammoh O, Qnais E, Barakat M, Oqal M, Abudalo R, Alotaibi BS, Aljabali AAA, Alzaghari LF, Alqudah A.   +9 more
europepmc   +1 more source

“Unclassical” Combination of Smell Dysfunction, Altered Abdominal Nociception and Human Hypertension Associated “Classical” Adrenal-Augmentation

, 2015
Daniel S. Leon-Ariza, Juan S. León-Ariza, Fidias E. Leon‐Sarmiento   +2 more
openalex   +2 more sources

The Buprenorphine Paradox: How Buprenorphine Triggers and Resolves Opioid Withdrawal

Addiction Biology, Volume 31, Issue 3, March 2026.
Buprenorphine can either precipitate or relieve opioid withdrawal depending on the timing of administration relative to full opioid agonist exposure. The article proposes that buprenorphine promotes mu‐opioid receptor (MOR) externalization and resensitization, creating a temporary signaling gap that explains precipitated withdrawal when full agonists ...
Mehdi Haghdoost, Jennifer LaBranche, Matthew Roberts, Victor W. Li, Jane J. Kim, James S. H. Wong, Pouya Azar   +6 more
wiley   +1 more source

Risk Factors for Intolerable Postoperative Pain After Vitreoretinal Surgery Under AoA-Guided General Anesthesia with Intravenous COX-3 Inhibitors: A Post Hoc Analysis. [PDF]

Pharmaceuticals (Basel)
Stasiowski MJ, Marczak K, Lyssek-Boroń A, Zmarzły N.   +3 more
europepmc   +1 more source

Nociception-specific blink reflex: pharmacology in healthy volunteers [PDF]

, 2015
Juana Marin, AR Gantenbein, Koen Paemeleire, H Kaube, Peter J. Goadsby   +4 more
openalex   +1 more source

Non‐Pulmonary Mechanisms of Action of Ambroxol in In Vivo Experimental Models: a Systematic Review

Fundamental &Clinical Pharmacology, Volume 40, Issue 2, March 2026.
ABSTRACT Background Repositioning offers a cost‐effective approach to discovering new therapeutic applications for existing medications. Ambroxol, primarily used as a mucolytic for respiratory diseases, has demonstrated anti‐inflammatory, analgesic, and antioxidant properties, suggesting potential benefits in non‐pulmonary conditions.
Michelline Joana Tenório Albuquerque Madruga Mesquita, Anne Caroline Silva Nogueira da Cruz, Rafael de Abreu Lima, Joana Tenório‐Meireles, Arney José Nogueira Farias, Isabela Nogueira Santos, Gustavo Frota, Taciana Gabrielle Pinheiro de Moura Carvalho, Rafael Antônio Freire Carvalho, Jorge Antônio Meireles‐Teixeira, Tereza Prazeres, Rafael Cardoso Carvalho, Maria do Socorro de Sousa Cartágenes, João Batista Santos Garcia   +13 more
wiley   +1 more source

Pupillary Pain Index-Guided Postoperative Pain Therapy in ENT Surgery: A Randomized Trial. [PDF]

J Clin Med
Windpassinger M, Prusak M, Yeghiazaryan L, Ristl R, Ott S, Müller-Wirtz LM, Ruetzler K.   +6 more
europepmc   +1 more source

Threshold and rate sensitivity of low‐threshold thermal nociception

, 2010
Barry G. Green, Carol Akirav
openalex   +1 more source

Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study

Headache: The Journal of Head and Face Pain, Volume 66, Issue 3, Page 658-671, March 2026.
Abstract Objective To evaluate the effect of erenumab treatment beyond monthly migraine days in patients with high‐frequency episodic migraine who did not respond to at least one previous migraine preventive treatment. Background Reduction in monthly migraine days has been the efficacy standard for migraine preventive treatments; however, it does not ...
Gabriel Paiva da Silva Lima, Renata Rao, Gyöngyi Szabó, Sebastian Szklener, Cristina Tassorelli, Marcin Nastaj, Denise E. Chou, Ani C. Khodavirdi, Mahan Chehrenama, Yineng Zhu, Ajay K. Bhatia, David W. Dodick   +11 more
wiley   +1 more source

Corticosteroids for Managing TRK Inhibitor Withdrawal Pain: A Report on Two Cases. [PDF]

Curr Oncol
Marcoux N, Grenier LP.
europepmc   +1 more source